General
Preferred name
Vitamin E
Synonyms
Tocopherol (vit e) ()
E-Caps ()
Fort-E-Vite Plus ()
Tocopheryl Acetate, dl-Alpha ()
Natopherol ()
Davina ()
Bio-E-Vit ()
Sigma ()
Tocopheryl Acetate, d-Alpha ()
Eprolin ()
Tocopheryl Acid Succinate, d-Alpha ()
Harris ()
Fort-E-Vite 1000 ()
Fort-E-Vite ()
Fort-E-Vite Super Plus ()
Alpha-tocopherol ()
Jarrow For ()
(+)-¦Á-Tocopherol ()
D-¦Á-Tocopherol ()
¦Á-Vitamin E ()
ALPHA-TOCOPHEROL ()
(+)-alpha-Tocopherol ()
D-α-Tocopherol ()
5,7,8-Trimethyltocol ()
Tocofersolan ()
DL-α-Tocopherol ()
alpha-TOCHOPHEROL ()
Ephanyl ()
(+)-??-Tocopherol ()
Tocopherol (R,S) ()
5,7,8-Trimethyltocol(+)-alpha-Tocopherol ()
vitamin-E ()
Tocopherol ()
α-Vitamin E ()
rel-α-Vitamin E ()
DL-alpha-Tocopherol ()
rel-¦Á-Vitamin E ()
rel-D-¦Á-Tocopherol ()
(+)-α-Tocopherol ()
rel-D-α-Tocopherol ()
??-Vitamin E ()
E307 ()
P&D ID
PD010193
CAS
11105-14-9
59-02-9
2074-53-5
10191-41-0
Tags
available
drug
Approved by
FDA
Drug indication
Cardiovascular disease
Drug Status
approved
withdrawn
investigational
nutraceutical
vet_approved
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PHARMACODYNAMICS Vitamin E is a collective term used to describe 8 separate fat soluble antioxidants, most commonly alpha-tocopherol[A176104]. Vitamin E acts to protect cells against the effects of free radicals, which are potentially damaging by-products of the body's metabolism. Vitamin E deficiency is seen in persons with abetalipoproteinemia, premature, very low birth weight infants (birth weights less than 1500 grams, or 3½ pounds), cystic fibrosis, and cholestasis and severe liver disease[A176104]. Preliminary research suggests vitamin E may help prevent or delay coronary heart disease and protect against the damaging effects of free radicals, which may contribute to the development of chronic diseases such as cancer[A237]. It also protects other fat-soluble vitamins (A and B group vitamins) from destruction by oxygen[A239]. Low levels of vitamin E have been linked to increased incidence of breast and colon cancer[L5725].
MOA The mechanism of action for most of vitamin E's effects are still unknown[A176104,A176107]. Vitamin E is an antioxidant, preventing free radical reactions with cell membranes[A176360]. Though in some cases vitamin E has been shown to have pro-oxidant activity[A176360]. One mechanism of vitamin E's antioxidant effect is in the termination of lipid peroxidation[A176363]. Vitamin E reacts with unstable lipid radicals, producing stable lipids and a relatively stable vitamin E radical[A176363]. The vitamin E radical is then reduced back to stable vitamin E by reaction with ascorbate or glutathione[A176363].
INDICATION Vitamin E supplementation is indicated for treatment of vitamin E deficiency which can occur in cystic fibrosis, cholestasis and severe liver disease, abetalipoproteinemia or simply poor diet[A176104,L3063].
ROE Alpha tocopherol is excreted in urine as well as bile in the feces mainly as a carboxyethyl-hydrochroman (CEHC) metabolite, but it can be excreted in it's natural form [A176137].
TOXICITY There is no data available for effects in pregnancy, breast feeding, hepatic impairment, or renal impairment. However, it appears that the process of vitamin E elimination is strict and self regulating enough that vitamin E toxicity is exceedingly rare[A176137,A176210]. Studies showing adverse effects from excess vitamin E generally involve people consuming more than 1000mg/day for weeks to months[L3063].
ABSORPTION 10-33% of deuterium labelled vitamin E is absorbed in the small intestine[A176110,L3063]. Absorption of Vitamin E is dependant upon absorption of the fat in which it is dissolved[L3063,A176104]. For patients with poor fat absorption, a water soluble form of vitamin E may need to be substituted such as tocopheryl polyethylene glycol-1000 succinate[L3063]. In other studies the oral bioavailability of alpha-tocopherol was 36%, gamma-tocotrienol was 9%[A32447]. The time to maximum concentration was 9.7 hours for alpha-tocopherol and 2.4 hours for gamma-tocotrienol[A32447].
HALF-LIFE 44 hours in premature neonates given a 20mg/kg intramuscular injection[A176113]. 12 minutes in intravenous injection of intestinal lymph[A176363].
MOA The mechanism of action for most of vitamin E's effects are still unknown[A176104,A176107]. Vitamin E is an antioxidant, preventing free radical reactions with cell membranes[A176360]. Though in some cases vitamin E has been shown to have pro-oxidant activity[A176360].; ; One mechanism of vitamin E's antioxidant effect is in the termination of lipid peroxidation[A176363]. Vitamin E reacts with unstable lipid radicals, producing stable lipids and a relatively stable vitamin E radical[A176363]. The vitamin E radical is then reduced back to stable vitamin E by reaction with ascorbate or glutathione[A176363].
ABSORPTION 10-33% of deuterium labelled vitamin E is absorbed in the small intestine[A176110,L3063]. Absorption of Vitamin E is dependant upon absorption of the fat in which it is dissolved[L3063,A176104]. For patients with poor fat absorption, a water soluble form of vitamin E may need to be substituted such as tocopheryl polyethylene glycol-1000 succinate[L3063].; ; In other studies the oral bioavailability of alpha-tocopherol was 36%, gamma-tocotrienol was 9%[A32447]. The time to maximum concentration was 9.7 hours for alpha-tocopherol and 2.4 hours for gamma-tocotrienol[A32447].
METABOLISM Alpha and gamma tocopherol are undergo beta oxidation and a process mediated by cytochrome P450s such as CYP4F2, CYP3A4, and CYP3A5[A176155]. These processes convert alpha and gamma tocopherol to alpha-CEHC (2,5,7,8-tetramethyl-2-(2’-carboxyethyl)-6-hydroxychroman) and gamma-CEHC (2,7,8-trimethyl-2-(2’-carboxyethyl)-6-hydroxychroman) respectively, however the full process is not known[A176155].
PRICE 29
DESCRIPTION ¦Á-Vitamin E ((+)-¦Á-Tocopherol), a naturally occurring vitamin E form, is a potent antioxidant[1][2].
DESCRIPTION rel-¦Á-Vitamin E (rel-D-¦Á-Tocopherol) is a vitamin with antioxidant properties and also a mixture[1].
DESCRIPTION ??-Vitamin E (Dexrabeprazole Sodium) is a naturally-occurring form of vitamin E, a fat-soluble vitamin with potent antioxidant properties.
DESCRIPTION Tocopherol is a lipid-soluble form of vitamin E. It is used in many skin creams and multivitamin preparations as an antioxidant. (Enamine Bioactive Compounds)
DESCRIPTION α-Vitamin E (Dexrabeprazole Sodium) is a naturally-occurring form of vitamin E, a fat-soluble vitamin with potent antioxidant properties. (TargetMol Bioactive Compound Library)
DESCRIPTION DL-alpha-Tocopherol (Ephanyl) is a synthetic vitamin E that protects skin fibroblasts from the cytotoxic effects of UV light and has antioxidant properties. (TargetMol Bioactive Compound Library)
Cell lines
0
Organisms
3
Compound Sets
16
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Enamine Bioactive Compounds
JUMP-Target 1 Compound Set
MedChem Express Bioactive Compound Library
NPC Screening Collection
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Withdrawn 2.0
External IDs
55
Properties
(calculated by RDKit )
Molecular Weight
430.38
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
1
Rotatable Bonds
12
Ring Count
2
Aromatic Ring Count
1
cLogP
8.84
TPSA
29.46
Fraction CSP3
0.79
Chiral centers
3.0
Largest ring
6.0
QED
0.36
Structural alerts
1
Singlet oxygen quenching
Nuisance compounds
Custom attributes
(extracted from source data)
Pathway
NF-¦ÊB
Apoptosis
Chromatin/Epigenetic
Cytoskeletal Signaling
Immunology/Inflammation
Metabolism
Microbiology/virology
NF-κB
oxidation-reduction
Anti-infection
Metabolic Enzyme/Protease
Target
Bacterial
Endogenous Metabolite
Environmental Pollutants
Ferroptosis
Influenza Virus
Reactive Oxygen Species (ROS)
antioxidant
ALOX5, DGKA, NR1I2, PPP2CA, PPP2CB, PRKCA, PRKCB, SEC14L2, SEC14L3, SEC14L4
PRKCB
GST Mu 3
GST omega-1
GSTP
PKC
Reactive Oxygen Species
SEC14-like protein
VE
MOA
LDL oxidation inhibitor, PKC inhibitor
ATC
A11HA03
Toxicity type
hepatic
Source data